agilon health, inc. - Common stock, $0.01 par value (AGL)

CUSIP: 00857U206

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class
Equity / Common stock, $0.01 par value
Total 13F shares
15,053,768
Total 13F value
$119,061,205
Holder snapshot 6 visible 7 signals
Share change
+14,237,518
Put/Call ratio
8.4%
SEC-reported price per share
$7.91
Number of holders
90
Value change
+$112,604,666
Number of buys
84
Open additional details 1 more signal available
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
16,687,735

Security key

00857U206

Report period

Q1 2026

Institutions

90

Top holders

10

AGL full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 agilon health, inc. SEC filings agilon health, inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AGL - agilon health, inc. - Common stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
MORGAN STANLEY
Disclosed value leader
MORGAN STANLEY
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 13F Lead comparable stake: 12% 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.
Comparable ownership Top 5
MORGAN STANLEY 12%
North Peak Capital Management, LLC 9.5%
GOLDMAN SACHS GROUP INC 6.1%
AQR CAPITAL MANAGEMENT LLC 5.9%
VANGUARD GROUP INC 4.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13D/G 13F
Company
13D/G 13F
12%
$192,768,956
50,200,249 shares
 $0 31 Mar 2025
North Peak Capital Management, LLC
13D/G 13F
Company
13D/G 13F
9.5%
$40,594,316
39,411,957 shares
 +$18,411,536 30 Sep 2025
GOLDMAN SACHS GROUP INC
13F 13D/G
Company · THE GOLDMAN SACHS GROUP, INC.
13F 13D/G
6.1%
from 13D/G
$13,812,025
20,055,214 shares
 — 31 Dec 2025
AQR CAPITAL MANAGEMENT LLC
13F 13D/G
Company
13F 13D/G
5.9%
from 13D/G
$7,032,843
10,211,767 shares
 — 31 Dec 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group
13F 13D/G
4.4%
from 13D/G
$12,623,725
18,321,808 shares
 — 31 Dec 2025
FMR LLC
13D/G 13F
Company
13D/G 13F
3.7%
$15,838,857
15,377,531 shares
 -$24,084,688 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
90
Shares
15,053,768
Rows available
90
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q1 2026 holders
90
Holder diff
89
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .